Addus HomeCare Co. (NASDAQ:ADUS) Stock Holdings Lowered by Amalgamated Bank

Amalgamated Bank lowered its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 2.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 5,195 shares of the company’s stock after selling 135 shares during the period. Amalgamated Bank’s holdings in Addus HomeCare were worth $691,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Ellsworth Advisors LLC bought a new position in shares of Addus HomeCare during the second quarter worth about $598,000. Quadrature Capital Ltd bought a new position in shares of Addus HomeCare during the first quarter worth about $1,557,000. Lord Abbett & CO. LLC bought a new position in shares of Addus HomeCare during the first quarter worth about $8,274,000. SG Americas Securities LLC bought a new position in shares of Addus HomeCare during the second quarter worth about $842,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the period. Institutional investors own 95.35% of the company’s stock.

Analyst Ratings Changes

ADUS has been the subject of several research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday. Stephens upped their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. KeyCorp initiated coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Oppenheimer upped their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, Macquarie reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 75.23 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now owns 3,866 shares in the company, valued at $502,695.98. This represents a 11.45 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,917 shares of company stock worth $3,050,082. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Trading Down 1.9 %

Shares of NASDAQ ADUS opened at $119.78 on Friday. Addus HomeCare Co. has a twelve month low of $85.43 and a twelve month high of $136.12. The company has a market capitalization of $2.17 billion, a price-to-earnings ratio of 27.41, a PEG ratio of 2.15 and a beta of 1.04. The firm has a 50-day moving average of $128.99 and a two-hundred day moving average of $122.24.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.03 EPS. As a group, research analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.